Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Best wishes to you as well, SYN00GOLD - at some point good will prevail.
I do not look in often, but am also carrying a reasonable volume of SNG shares. I had no doubts in February 2020 and have no doubts now. Beta Interferon 1a via inhalation will prove ALL hurdles and deliver for shareholders. Ignore day to day and week to week comments and negative diatribe.
The company are on track, and will deliver. This drug is NOT co-dependent on Covid. This drug will be needed for a population of folks for a myriad of respiratory conditions. Keep the faith and I wish all investors best wishes.
Hollllllllllllllllllllllllllllddddddddddddddddddddddddddddd :-)
Thank you for that clarification Alphageddon. Additionally for the information about the Phase 2 enrolment. The fact that the enrolment is continuing is a positive sign in itself. Perhaps Dr. Castro did not misspeak after all, but rather he preempted information that will be issued subsequently in line with (warp-speed?) trial protocols and procedures? Further information such as an emergency use authorisation, or as you stated a conditional pre-order would no doubt stimulate the share price - well upwards from its current trading range.
Like you, I am heavily invested in this company. It was always my strategy to remain invested through thick and thin until my target price of 300p was reached, and to quickly re-evaluate my position at that stage. It could well be another three to four months until all the results of the clinical trials, and their evaluation, are known. Meanwhile there could be various other emerging scenarios? I have remained positive about the eventual outcome of my investment since I purchased my first shares last August. This remains the case
Regards, and with good wishes.
It will be progression from Activ-2 Phase 2 to Activ-2 Phase 3. SNG001 won't be moved onto the separate Activ-3 trial. Apart from that I'm in agreement TLWilliams :)
The good news is that patients are continuing to be enrolled onto the Activ2 trial even though SNG has completed phase 2 enrolment - my understanding is that all phase 2 patients will be counted in phase 3 numbers.
From all the crumbs of information that have been gleaned that are pointing to this announcement being almost certain, its a frustrating wait since Castrogate :) I just wonder if there will be more announced at the same time, such as a conditional pre-order? My hope is to top slice 10-20% on good news anyway as Im massively overweight on this share
I agree. No two shares are alike. However, in recent months, shares in Synairgen have shown a similar trading pattern to those of a company I was invested in more than three years ago. The endpoint of that investment was a buyout, with the share price doubling overnight.
This is an unlikely scenario for Synairgen. However, further positive data from the ACTIV-2 clinical trial with a seamless transition to ACTIV-3 would have a significant effect on the share price. This would seem to be the next piece of news in the pipeline? One cannot discount other possible scenarios, but until there is a development, investors can but remain calm and patient. Everyone has different methods of relaxation; I tend to listen to music from the late 17th and 18th centuries including this piece of "baroque and roll".
https://www.youtube.com/watch?v=WrPwZLTuIqI
It finished in the red (150.33p)
Yes nice finish in the blue I got a feeling we might have a good Friday
Sincerely hoping you’re right.
In danger of developing bed sores sitting on my hands. Not to mention seeing other investments I can’t take full advantage of, tad frustrating.
Final top up for me today ..... and a nice little leap in the SP to finish.
I have a feeling things are going to start hotting up soon.